The purpose of this study is to determine whether combination therapy with Tolterodine ER and Tamsulosin is more effective than monotherapy with tamsulosin alone in reducing stent symptoms. The second purpose is to determine if people have less stent discomfort if they take these medications starting 2 weeks before the stent is placed The investigators hope to show that the addition of Tolterodine ER to Tamsulosin will provide added benefits in reducing stent symptoms in patients who have had unilateral placement of a ureteral stent.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Ureteral Stent Symptom Questionnaire Score Up to 24 Hours Prior to Stent Insertion
Timeframe: Up to 24 hours prior to stent insertion
Ureteral Stent Symptom Questionnaire Score
Timeframe: 42-48 hours post-stent insertion
Ureteral Stent Symptom Questionnaire Score 5-7 Days Post-stent Insertion
Timeframe: 5-7 days post-stent insertion
Ureteral Stent Symptom Questionnaire Score Up to 24 Hours After Stent Removal
Timeframe: Up to 24 hours after stent removal. Removal will occur 5 to 7 days after insertion.